MED-PACE focuses on the treatment of functional and metabolic diseases by neuromodulation. The company was founded by Dr. Jiande Chen, an expert in neuromodulation and gastrointestinal dynamics at Johns Hopkins university school of medicine, and Dr. Jianfeng Chen, an expert in the National Thousand Talents Plan. As one of the pioneers in the research and clinical application of neuromodulation, the founding team has obtained a series of clinical achievements in the treatment of functional diseases by neuromodulation. At present, in the field of inflammatory bowel disease, diabetes and functional gastroenteropathy, MED-PACE is developing innovative applications of neuromodulation therapy based on a large number of frontier basic researches at home and abroad. The company have obtained CFDA certificates in some products.